Applicant, as named in the Orange Book

Horizon Therap Us

Next listed expiry: Ravicti on 22 Sep 2030. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Ravicti NDA 203284 glycerol phenylbutyrate	glycerol phenylbutyrate	22 Sep 2030 patent, carve-out possible	patent, carve-out possible

Ravicti · Generic approved · ANDA 219540, MsnApproved 15 Apr 2026Detected 25 Oct 2026
Ravicti · Generic approved · ANDA 207694, LupinApproved 30 Apr 2026Detected 25 Oct 2026
Ravicti · Generic approved · ANDA 220568, Navinta LlcApproved 23 Apr 2026Detected 25 Oct 2026
Ravicti · Generic approved · ANDA 220579, Pai HoldingsApproved 28 Jul 2026Detected 25 Oct 2026
Ravicti · Generic approved · ANDA 218738, Teva Pharms IncApproved 15 Apr 2026Detected 25 Oct 2026
Buphenyl · Generic approved · ANDA 220418, Navinta LlcApproved 17 Feb 2026Detected 25 Oct 2026
Ravicti · Generic approved · ANDA 220313, Aurobindo PharmaApproved 15 Apr 2026Detected 25 Oct 2026